$131 Million is the total value of Wildcat Capital Management, LLC's 19 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LPLA | LPL FINANCIAL HOLDINGS INC | $13,608,000 | +6.9% | 208,401 | 0.0% | 10.41% | -0.8% | |
| EDIT | EDITAS MEDICINE INC | $6,652,000 | +8.1% | 185,668 | 0.0% | 5.09% | +0.2% | |
| PLAY | DAVE & BUSTER'S ENTERTAINMEN | $5,712,000 | +14.0% | 120,000 | 0.0% | 4.37% | +5.8% | |
| SNNAQ | SIENNA BIOPHARMACEUTICALS IN | $4,490,000 | -19.1% | 295,613 | 0.0% | 3.44% | -25.0% | |
| APPF | APPFOLIO INC | $3,508,000 | +49.7% | 57,372 | 0.0% | 2.68% | +38.8% | |
| PLYA | PLAYA HOTELS & RESORTS NV | $3,240,000 | +5.7% | 300,000 | 0.0% | 2.48% | -2.0% | |
| SRNE | SORRENTO THERAPEUTICS INC | $2,994,000 | +39.8% | 415,765 | 0.0% | 2.29% | +29.7% | |
| NK | NANTKWEST INC | $1,703,000 | -21.3% | 556,453 | 0.0% | 1.30% | -27.0% | |
| NH | NANTHEALTH INC | $663,000 | +8.5% | 200,373 | 0.0% | 0.51% | +0.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COSTAR GROUP INC | 32 | Q3 2022 | 48.3% |
| UROGEN PHARMA LTD | 26 | Q3 2023 | 17.3% |
| META PLATFORMS INC | 26 | Q3 2023 | 9.9% |
| ALLOGENE THERAPEUTICS INC | 18 | Q3 2023 | 22.4% |
| GOOSEHEAD INSURANCE INC -A | 18 | Q3 2023 | 15.4% |
| SABINE RTY TRUST | 18 | Q3 2021 | 11.3% |
| LPL FINL HLDGS INC | 18 | Q1 2019 | 12.7% |
| PLAYA HOTELS & RESORTS NV | 18 | Q3 2021 | 3.4% |
| NANTKWEST INC | 17 | Q3 2019 | 22.0% |
| SORRENTO THERAPEUTICS INC | 17 | Q2 2019 | 7.0% |
View Wildcat Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Skillz Inc. | January 05, 2023 | 19,596,988 | 5.6% |
| UroGen Pharma Ltd. | February 14, 2022 | 533,139 | 2.4% |
| Skillz Inc. | March 08, 2021 | 21,832,022 | 7.5% |
| NantKwest, Inc. | February 13, 2018 | 808,974 | 1.0% |
| Sorrento Therapeutics, Inc. | February 13, 2018 | 1,738,232 | 2.2% |
View Wildcat Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 3 | 2024-04-08 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-09 |
| PX14A6G | 2023-11-03 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-07 |
View Wildcat Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.